Santhera Pharmaceuticals Holding AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Santhera Pharmaceuticals Holding AG with three other
pharmaceutical manufacturers in Europe:
Millet Innovation Sa
sales of 21.44 million Euro [US$24.22 million]
of which 92%
was Pharmacies & Pharmaceutical Wholesale De),
Science In Sport Plc
of the United Kingdom
(£15.62 million [US$20.36 million]
of which 89%
was Core), and
Vistin Pharma ASA
based in Norway
(176.69 million Norwegian Kroner [US$20.80 million]
During the year ended December of 2017, sales at
Santhera Pharmaceuticals Holding AG were 22.94 million Swiss Francs (US$22.69 million).
increase of 20.5%
versus 2016, when the company's sales were 19.03 million Swiss Francs.
This was the fourth straight year of sales growth at Santhera Pharmaceuticals Holding AG.